Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NONE | Common Stock | Sale | -$3.97M | -270K | -11.05% | $14.69* | 2.17M | Dec 4, 2023 | Direct | F1, F2, F3 |
holding | NONE | Common stock | 30K | Dec 4, 2023 | Held by ICCA Labs, LLC | F4 |
Id | Content |
---|---|
F1 | The reported sale was executed on the Australian Securities Exchange (the "ASX") as Chess Depositary Interests ("CDIs") and sold using Australian Dollars. The CDIs are traded on the ASX and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. |
F2 | This price is expressed in United States Dollars using the conversion rate on December 4, 2023. |
F3 | Includes 1,171,291 shares of the Issuer's common stock underlying 3,513,873 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Also includes 60,572 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
F4 | The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |